Skip to content

Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis

Fluid Therapy and Cerebral Injury in Pediatric Diabetic Ketoacidosis

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01365793
Enrollment
1389
Registered
2011-06-03
Start date
2010-11-30
Completion date
2017-01-31
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Edema, Diabetic Ketoacidosis

Keywords

cerebral edema, diabetic ketoacidosis, pediatric diabetes, fluid therapy

Brief summary

The investigators will conduct a randomized controlled trial comparing four different intravenous (IV) fluid treatment protocols for pediatric diabetic ketoacidosis (DKA). Two rates of rehydration will be compared; a more rapid rate and a slower rate. Within each of these two basic rehydration protocols, the investigators will vary the type of rehydration fluid used (0.9% saline or 0.45% saline). The investigators will compare the different treatments by conducting assessments of neurological injury, by measuring the frequency of significant cerebral edema, and by measuring long-term neurocognitive function. These studies will allow us to determine whether variations in IV fluid treatment protocols affect acute neurological outcomes of DKA. Additionally, they will provide important data regarding the impact of DKA and DKA treatment on long-term neurocognitive function in children. In this way, the investigators hope to identify a more ideal fluid management strategy for children with DKA. Previous studies have suggested that DKA may cause blood flow to the brain to be reduced and that brain injury might result from this reduction in blood flow and/or the effects of re-establishment of normal blood flow during DKA treatment with insulin and iv fluids. The investigators hypothesize that more rapidly re-establishing normal blood flow to the brain during DKA, by giving fluids more rapidly and using fluids with a higher sodium (salt) content, will help to minimize brain injury caused by DKA.

Detailed description

These data will be compared to observational data from children with type 1 diabetes without DKA.

Interventions

DRUG0.45% saline replacement fluid

10cc/Kg bolus of 0.9% saline followed by 0.45% saline used as the replacement fluid

DRUG0.9% saline replacement fluid

10cc/Kg bolus of 0.9% saline followed by 0.9% saline used as the replacement fluid.

DRUG0.45% saline intravenous fluid

0.45% saline fluid

DRUG0.9% saline Intravenous fluid

0.9% saline fluid

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
No

Inclusion criteria

* must present or be transferred to a participating emergency department * age less than 18 years * diagnosis of DKA * serum glucose or fingerstick glucose concentration \>300 mg/dL * venous pH \< 7.25 OR serum bicarbonate concentration \< 15 mmol/L.

Exclusion criteria

* patients with underlying neurological disorders or neurocognitive deficits which would affect either mental status testing during treatment or subsequent neurocognitive testing after recovery * patients who present with concomitant alcohol or drug use, head trauma, meningitis or other conditions which might affect neurological function * patients transferred to one of the participating emergency departments after initiation of DKA treatment other than one 10cc/kg intravenous bolus of 0.9% saline * patients who are known to be pregnant at time of ED evaluation * patients who have been enrolled in this study twice previously * patients for whom the treating physician believed a specific fluid and electrolyte regimen was warranted * patients for whom informed consent could not be obtained within 1 hour after completion of the initial fluid bolus, or within 2 hours from initiation of fluids, whichever is longer * Patients who have been receiving IV fluids at a maintenance rate or greater (defined by the 4-2-1 rule) for more than two hours; OR * Patients for whom it has been more than four hours since DKA therapy (IV fluids, IV bolus, or IV insulin) began; OR * Patients who have been given hyperosmolar therapy (i.e. mannitol or 3% normal saline) prior to or since arriving at one of the participating PECARN emergency departments; OR * Patients for whom the treating physician intends to immediately administer hyperosmolar therapy (i.e. mannitol or 3% normal saline); OR * Patients whose baseline GCS is 11 or less.

Design outcomes

Primary

MeasureTime frameDescription
the Number of Participants With Glasgow Coma Score (GCS) < 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)24 hoursThe primary outcome is the binary indicator that a patient's GCS score drops below 14 (i.e. abnormal score) within the first 24 hours of treatment of DKA. There will be two treatment factors: sodium concentration of re-hydration fluids and rate of rehydration. These effects will be tested separately, using the Mantel-Haenszel chi-square test, stratified by hospital, and by the other main factor.

Secondary

MeasureTime frameDescription
Frequency of Clinically Apparent Brain Injury24 hoursDeterioration in neurological status requiring interventions such as hyperosmolar therapy or endotracheal intubation, or resulting in death. This outcome was determined by an adjudication committee.
Hourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)24 hoursThe Digit Span subtest is adapted from the Wechsler Intelligence Scale for Children, 4th version (WISC-IV) and it assesses working memory. It consists of a Digit Span Forward task in which individuals are asked to repeat numbers in the same sequence as they were presented verbally and a Digit Span Backward task in which participants repeat the numbers in the reversed order to which they were heard. Each task yields a score ranging from 0 to 16. Higher scores represent better outcomes for this test. The trajectory of digit span scores during the course of the hospitalization was used to assess improvements in mental status and whether these varied systematically as a function of treatment protocol. Digit span measurements were collected every four hours during waking hours (7AM to 10PM). The measure analyzed is the average linear change in scores between enrollment and either 24-hours or DKA resolution, whichever occurred first.
Mean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.3 monthsContextual memory was assessed via color and spatial-position tasks. Color-Task: black-ink items on a white square background were shown on a computer screen with a colored border. Subjects were asked to remember the item and the item's border color. Items were shown for 1 second, followed by a 1-second interval in which a fixation point was shown. Then, subjects were given a self-paced recognition test including studied drawings and new drawings shown in random order with no color border. Subjects determined if they had seen the drawing before. For recognized drawings, subjects reported the previously shown border color. Spatial-Position task: identical to the color task except that the items instead varied in their spatial position on the computer screen. The item-context association rate is the rate of correct item-color and item-spatial position recalled over the total of previously viewed items correctly recognized. Score range: 0-1 with higher scores indicating a better outcome.
Intelligence Quotient (IQ) Testing3 monthsIQ was assessed with the WASI (6-18 year olds) or WPPSI-III (3-5 year olds) at the 3 month follow-up visit. The Wechsler Abbreviated Scale of Intelligence (WASI) is a measure of IQ designed for individuals aged 6 to 89. The WASI includes four subtests; the Block Design and Matrix Reasoning tests measure Performance IQ, and the Vocabulary and Similarities tests measure Verbal IQ. Full scale IQ was computed from these scores and used for analyses. Scores typically vary from 75 to 135 with higher scores representing a better outcome.

Countries

United States

Participant flow

Participants by arm

ArmCount
Rapid Rehydration Using 0.45% Saline Replacement Fluid
This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.
344
Rapid Rehydration Using 0.9% Saline Replacement Fluid
This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.
351
Slower Rehydration Using 0.45% Saline Replacement Fluid
This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.
345
Slower Rehydration Using 0.9% Saline Replacement Fluid
This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.
349
Total1,389

Baseline characteristics

CharacteristicRapid Rehydration Using 0.45% Saline Replacement FluidRapid Rehydration Using 0.9% Saline Replacement FluidSlower Rehydration Using 0.45% Saline Replacement FluidSlower Rehydration Using 0.9% Saline Replacement FluidTotal
Age, Customized
0 to less than 6 years old
43 Participants42 Participants42 Participants35 Participants162 Participants
Age, Customized
6 to less than 18 years old
301 Participants309 Participants303 Participants314 Participants1227 Participants
Race/Ethnicity, Customized
Ethnicity
Hispanic or Latino
48 Participants62 Participants49 Participants69 Participants228 Participants
Race/Ethnicity, Customized
Ethnicity
Not Hispanic or Latino, Other, or Unknown
296 Participants289 Participants296 Participants280 Participants1161 Participants
Race/Ethnicity, Customized
Race
Black or African American
73 Participants82 Participants68 Participants63 Participants286 Participants
Race/Ethnicity, Customized
Race
Other
19 Participants14 Participants16 Participants23 Participants72 Participants
Race/Ethnicity, Customized
Race
Unknown
17 Participants23 Participants14 Participants20 Participants74 Participants
Race/Ethnicity, Customized
Race
White
235 Participants232 Participants247 Participants243 Participants957 Participants
Sex: Female, Male
Female
179 Participants187 Participants187 Participants186 Participants739 Participants
Sex: Female, Male
Male
165 Participants164 Participants158 Participants163 Participants650 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
1 / 3420 / 3440 / 3380 / 347
other
Total, other adverse events
112 / 342124 / 344117 / 338129 / 347
serious
Total, serious adverse events
5 / 3424 / 34411 / 33810 / 347

Outcome results

Primary

the Number of Participants With Glasgow Coma Score (GCS) < 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)

The primary outcome is the binary indicator that a patient's GCS score drops below 14 (i.e. abnormal score) within the first 24 hours of treatment of DKA. There will be two treatment factors: sodium concentration of re-hydration fluids and rate of rehydration. These effects will be tested separately, using the Mantel-Haenszel chi-square test, stratified by hospital, and by the other main factor.

Time frame: 24 hours

Population: Patients with a GCS of 14 or 15 at randomization

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rapid Rehydration Using 0.45% Saline Replacement Fluidthe Number of Participants With Glasgow Coma Score (GCS) < 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)10 Participants
Rapid Rehydration Using 0.9% Saline Replacement Fluidthe Number of Participants With Glasgow Coma Score (GCS) < 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)11 Participants
Slower Rehydration Using 0.45% Saline Replacement Fluidthe Number of Participants With Glasgow Coma Score (GCS) < 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)11 Participants
Slower Rehydration Using 0.9% Saline Replacement Fluidthe Number of Participants With Glasgow Coma Score (GCS) < 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)16 Participants
Comparison: The study uses a factorial experimental design, and tests two null hypotheses. The first of these hypotheses - the frequency of GCS score declines to \<14 is equal between the Rapid Rehydration and Slower Rehydration groups - is reported here. The analysis of the second hypothesis is reported below.p-value: 0.34Cochran-Mantel-Haenszel
Comparison: The study uses a factorial experimental design, and tests the two null hypotheses. The second of these hypotheses - the frequency of GCS score declines to \<14 is equal between the 0.45% Saline group and the 0.90% Saline group - is reported here. The analysis of the first hypothesis is reported above.p-value: 0.43Cochran-Mantel-Haenszel
Secondary

Frequency of Clinically Apparent Brain Injury

Deterioration in neurological status requiring interventions such as hyperosmolar therapy or endotracheal intubation, or resulting in death. This outcome was determined by an adjudication committee.

Time frame: 24 hours

Population: All randomized patients.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rapid Rehydration Using 0.45% Saline Replacement FluidFrequency of Clinically Apparent Brain Injury2 Participants
Rapid Rehydration Using 0.9% Saline Replacement FluidFrequency of Clinically Apparent Brain Injury2 Participants
Slower Rehydration Using 0.45% Saline Replacement FluidFrequency of Clinically Apparent Brain Injury5 Participants
Slower Rehydration Using 0.9% Saline Replacement FluidFrequency of Clinically Apparent Brain Injury3 Participants
Secondary

Hourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)

The Digit Span subtest is adapted from the Wechsler Intelligence Scale for Children, 4th version (WISC-IV) and it assesses working memory. It consists of a Digit Span Forward task in which individuals are asked to repeat numbers in the same sequence as they were presented verbally and a Digit Span Backward task in which participants repeat the numbers in the reversed order to which they were heard. Each task yields a score ranging from 0 to 16. Higher scores represent better outcomes for this test. The trajectory of digit span scores during the course of the hospitalization was used to assess improvements in mental status and whether these varied systematically as a function of treatment protocol. Digit span measurements were collected every four hours during waking hours (7AM to 10PM). The measure analyzed is the average linear change in scores between enrollment and either 24-hours or DKA resolution, whichever occurred first.

Time frame: 24 hours

Population: All randomized patients with digit span measured during DKA

ArmMeasureGroupValue (MEAN)Dispersion
Rapid Rehydration Using 0.45% Saline Replacement FluidHourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)Digit span recall test Forward slope0.065 Digit Span Change per HourStandard Error 0.01
Rapid Rehydration Using 0.45% Saline Replacement FluidHourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)Digit span recall test Backward slope0.052 Digit Span Change per HourStandard Error 0.009
Rapid Rehydration Using 0.9% Saline Replacement FluidHourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)Digit span recall test Backward slope0.053 Digit Span Change per HourStandard Error 0.009
Rapid Rehydration Using 0.9% Saline Replacement FluidHourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)Digit span recall test Forward slope0.058 Digit Span Change per HourStandard Error 0.01
Slower Rehydration Using 0.45% Saline Replacement FluidHourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)Digit span recall test Forward slope0.046 Digit Span Change per HourStandard Error 0.01
Slower Rehydration Using 0.45% Saline Replacement FluidHourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)Digit span recall test Backward slope0.042 Digit Span Change per HourStandard Error 0.009
Slower Rehydration Using 0.9% Saline Replacement FluidHourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)Digit span recall test Forward slope0.039 Digit Span Change per HourStandard Error 0.01
Slower Rehydration Using 0.9% Saline Replacement FluidHourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)Digit span recall test Backward slope0.043 Digit Span Change per HourStandard Error 0.009
Secondary

Intelligence Quotient (IQ) Testing

IQ was assessed with the WASI (6-18 year olds) or WPPSI-III (3-5 year olds) at the 3 month follow-up visit. The Wechsler Abbreviated Scale of Intelligence (WASI) is a measure of IQ designed for individuals aged 6 to 89. The WASI includes four subtests; the Block Design and Matrix Reasoning tests measure Performance IQ, and the Vocabulary and Similarities tests measure Verbal IQ. Full scale IQ was computed from these scores and used for analyses. Scores typically vary from 75 to 135 with higher scores representing a better outcome.

Time frame: 3 months

Population: All randomized subjects aged 3 years and older with 3-month follow-up and successful completion of IQ testing.

ArmMeasureValue (MEAN)Dispersion
Rapid Rehydration Using 0.45% Saline Replacement FluidIntelligence Quotient (IQ) Testing102 IQ pointsStandard Deviation 12
Rapid Rehydration Using 0.9% Saline Replacement FluidIntelligence Quotient (IQ) Testing102 IQ pointsStandard Deviation 13
Slower Rehydration Using 0.45% Saline Replacement FluidIntelligence Quotient (IQ) Testing102 IQ pointsStandard Deviation 13
Slower Rehydration Using 0.9% Saline Replacement FluidIntelligence Quotient (IQ) Testing103 IQ pointsStandard Deviation 13
Secondary

Mean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.

Contextual memory was assessed via color and spatial-position tasks. Color-Task: black-ink items on a white square background were shown on a computer screen with a colored border. Subjects were asked to remember the item and the item's border color. Items were shown for 1 second, followed by a 1-second interval in which a fixation point was shown. Then, subjects were given a self-paced recognition test including studied drawings and new drawings shown in random order with no color border. Subjects determined if they had seen the drawing before. For recognized drawings, subjects reported the previously shown border color. Spatial-Position task: identical to the color task except that the items instead varied in their spatial position on the computer screen. The item-context association rate is the rate of correct item-color and item-spatial position recalled over the total of previously viewed items correctly recognized. Score range: 0-1 with higher scores indicating a better outcome.

Time frame: 3 months

Population: All randomized subjects aged 6 years old and older with 3-month follow-up and successful completion of memory score tests, and d-prime (a measure of chance agreement) \>0.50

ArmMeasureValue (MEAN)Dispersion
Rapid Rehydration Using 0.45% Saline Replacement FluidMean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.0.60 Item-context association rateStandard Deviation 0.14
Rapid Rehydration Using 0.9% Saline Replacement FluidMean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.0.60 Item-context association rateStandard Deviation 0.14
Slower Rehydration Using 0.45% Saline Replacement FluidMean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.0.61 Item-context association rateStandard Deviation 0.14
Slower Rehydration Using 0.9% Saline Replacement FluidMean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.0.60 Item-context association rateStandard Deviation 0.14

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026